​我們的研究專注於小分子的設計、合成與生物評估，致力於探索創新藥物的可能性。

我們所開發的新化合物將進行癌症與腎臟纖維化疾病的治療效能評估，藉由結合分子設計與生物學方法，深入探討疾病機制並尋找潛在治療策略。

研究重點特別聚焦於血液性腫瘤、膠質母細胞瘤與大腸直腸癌，期望能透過跨領域的研究方法，推動新型藥物的開發並改善臨床治療選擇。

Our current research focuses on on the design, synthesis, and biological evaluation of small molecules, with the goal of advancing innovative therapeutic strategies.

The compounds we develop are systematically evaluated for their potential to treat cancer and kidney fibrosis, integrating molecular design with biological approaches to uncover disease mechanisms and identify novel interventions.

Our research places particular emphasis on hematologic malignancies, glioblastoma, and colorectal cancer, aiming to translate our discoveries into meaningful drug development and improved clinical options through interdisciplinary research.